Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 19, 2012
Development of the Shortness of Breath with Daily Activities questionnaire (SOBDA)
Kellee Howard, Pamela Berry, Jennifer Petrillo, et al.
Current Medical Research and Opinion
|
September 2, 2015
Three-year patient-reported visual function outcomes in diabetic macular edema managed with ranibizumab: the RESTORE extension study
Paul Mitchell, Pascale Massin, Susan Bressler, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
November 7, 2017
Measuring the impact of multiple sclerosis: Enhancing the measurement performance of the Multiple Sclerosis Impact Scale (MSIS-29) using Rasch Measurement Theory (RMT)
Sophie Cleanthous, Stefan Cano, Elizabeth Kinter, et al.
Journal of Huntington'S Disease
|
August 30, 2024
Rasch Measurement Theory (RMT) Analyses of the Huntington's Disease Everyday Functioning (Hi-DEF) to Evaluate Item Fit and Performance
Jennifer Petrillo, Ruta Sawant, Emma Elliott, et al.
JAMA Ophthalmology
|
August 27, 2013
Patient-reported visual function outcomes improve after ranibizumab treatment in patients with vision impairment due to diabetic macular edema: randomized clinical trial
Paul Mitchell, Neil Bressler, Keith Tolley, et al.
Plos One
|
June 4, 2015
Treatment Satisfaction and Well-Being in Patients with Myopic Choroidal Neovascularization Treated with Ranibizumab in the REPAIR Study
Winfried M Amoaku, Richard P Gale, Andrew J Lotery, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
July 27, 2014
Developing a utility index for the Aberrant Behavior Checklist (ABC-C) for fragile X syndrome
Cicely Kerr, Katie Breheny, Andrew Lloyd, et al.
Journal of Huntington'S Disease
|
February 20, 2025
Cognitive impairment in Huntington's disease and its impact on functioning: Concept elicitation and cognitive debriefing for the Huntington's Disease Everyday Functioning (Hi-DEF) scale
Jennifer Petrillo, A Alex Levine, Jason Johannesen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 28, 2010
Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): a patient-reported outcome (PRO) measure
Nancy Kline Leidy, Teresa K Wilcox, Paul W Jones, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
May 26, 2018
Addressing the targeting range of the ABILHAND-56 in relapsing-remitting multiple sclerosis: A mixed methods psychometric study
Sophie Cleanthous, Sara Strzok, Farrah Pompilus, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 19, 2012
Development of the Shortness of Breath with Daily Activities questionnaire (SOBDA)
Kellee Howard, Pamela Berry, Jennifer Petrillo, et al.
Current Medical Research and Opinion
|
September 2, 2015
Three-year patient-reported visual function outcomes in diabetic macular edema managed with ranibizumab: the RESTORE extension study
Paul Mitchell, Pascale Massin, Susan Bressler, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
November 7, 2017
Measuring the impact of multiple sclerosis: Enhancing the measurement performance of the Multiple Sclerosis Impact Scale (MSIS-29) using Rasch Measurement Theory (RMT)
Sophie Cleanthous, Stefan Cano, Elizabeth Kinter, et al.
Journal of Huntington'S Disease
|
August 30, 2024
Rasch Measurement Theory (RMT) Analyses of the Huntington's Disease Everyday Functioning (Hi-DEF) to Evaluate Item Fit and Performance
Jennifer Petrillo, Ruta Sawant, Emma Elliott, et al.
JAMA Ophthalmology
|
August 27, 2013
Patient-reported visual function outcomes improve after ranibizumab treatment in patients with vision impairment due to diabetic macular edema: randomized clinical trial
Paul Mitchell, Neil Bressler, Keith Tolley, et al.
Plos One
|
June 4, 2015
Treatment Satisfaction and Well-Being in Patients with Myopic Choroidal Neovascularization Treated with Ranibizumab in the REPAIR Study
Winfried M Amoaku, Richard P Gale, Andrew J Lotery, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
July 27, 2014
Developing a utility index for the Aberrant Behavior Checklist (ABC-C) for fragile X syndrome
Cicely Kerr, Katie Breheny, Andrew Lloyd, et al.
Journal of Huntington'S Disease
|
February 20, 2025
Cognitive impairment in Huntington's disease and its impact on functioning: Concept elicitation and cognitive debriefing for the Huntington's Disease Everyday Functioning (Hi-DEF) scale
Jennifer Petrillo, A Alex Levine, Jason Johannesen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 28, 2010
Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): a patient-reported outcome (PRO) measure
Nancy Kline Leidy, Teresa K Wilcox, Paul W Jones, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
May 26, 2018
Addressing the targeting range of the ABILHAND-56 in relapsing-remitting multiple sclerosis: A mixed methods psychometric study
Sophie Cleanthous, Sara Strzok, Farrah Pompilus, et al.
Page
of 3